Genetic and Clinical Analysis of Spinocerebellar Ataxia Type 36 in Mainland China
Overview
Affiliations
Spinocerebellar ataxia type 36 (SCA36) is a new SCA subtype recently reported in Japanese and Spanish pedigrees. To assess the frequency and clinical characteristics of SCA36 in patients from Mainland China, we combined the repeat-primed polymerase chain reaction method and Southern blot analysis to detect the GGCCTG hexanucleotide repeats of NOP56 in 364 probands with SCA, 126 probands with hereditary spastic paraplegia and 99 probands with amyotrophic lateral sclerosis (ALS). Systematic and targeted clinical evaluations and investigations were conducted in the SCA36 patients. As a result, eight autosomal dominant spinocerebellar ataxia (ADCA) pedigrees (a total of 13 patients) and one sporadic SCA (S-SCA) patient were identified as SCA36 in the SCA cohort, accounting for approximately 1.60% of the cases in the ADCA group and 0.32% of those in the S-SCA group in Mainland China. The characteristics include late onset and slow progression accompanied by acoustic impairments and 'possible' ALS phenotype in patients from Mainland China.
Another common genetic ataxia in South Korea: Spinocerebellar ataxia 36.
Ahn J, Lee S, Moon J, Han Y, Chang H, Youn J Eur J Hum Genet. 2025; .
PMID: 39994402 DOI: 10.1038/s41431-024-01783-9.
Morikawa T, Miura S, Uchiyama Y, Hiruki S, Sun Y, Fujioka R J Hum Genet. 2024; 69(9):411-416.
PMID: 38811808 DOI: 10.1038/s10038-024-01260-7.
Ruffo P, De Amicis F, La Bella V, Conforti F Cells. 2024; 13(8.
PMID: 38667292 PMC: 11049433. DOI: 10.3390/cells13080677.
Repeat expansions in are a cause of spinocerebellar ataxia Type 36 in the British population.
Lam T, Rocca C, Ibanez K, Dalmia A, Tallman S, Hadjivassiliou M Brain Commun. 2023; 5(5):fcad244.
PMID: 37810464 PMC: 10558097. DOI: 10.1093/braincomms/fcad244.
A Chinese SCA36 pedigree analysis of expansion region based on long-read sequencing.
Zou J, Wang F, Gong Z, Wang R, Chen S, Zhang H Front Genet. 2023; 14:1110307.
PMID: 37051597 PMC: 10083286. DOI: 10.3389/fgene.2023.1110307.